Physician profile
Kyle J Smith
NPI 1902817992
$9,428.53
in general payments reported to CMS, 2019-2025
39 companies · $1,180 in 2025
The $1,180 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $909 · 2020: $779 · 2021: $1,431 · 2022: $1,747 · 2023: $1,942 · 2024: $1,440 · 2025: $1,180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,561.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,523.08 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| Janssen Pharmaceuticals, INC | $778.83 | 2019-2024 | Xarelto |
| Medtronic Vascular, INC. | $618.80 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $453.55 | 2020-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $439.54 | 2019-2025 | Lifevest |
| Astellas Pharma US INC | $391.00 | 2019-2021 | |
| Amgen INC. | $375.87 | 2019-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $342.28 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $241.23 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $233.43 | 2021-2024 | Verquvo |
| Novo Nordisk INC | $226.62 | 2022-2023 | Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $225.85 | 2019-2023 | |
| Abbott Laboratories | $165.44 | 2023-2025 | Mitraclip, Viewmate, Amplatzer |
| Edwards Lifesciences Corporation | $159.66 | 2024-2025 | Sapien 3 Ultra Resilia |
| Pfizer INC. | $132.81 | 2019-2024 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $129.05 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $117.88 | 2021-2023 | Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.30 | 2019-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $83.50 | 2019-2024 | Farxiga |
| Cvrx, INC. | $81.40 | 2022-2025 | Barostim Neo System |
| Boston Scientific Corporation | $57.87 | 2022-2023 | |
| Irhythm Technologies, INC. | $50.65 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Lundbeck LLC | $45.58 | 2019-2021 | |
| Abiomed | $40.32 | 2025 | |
| Impulse Dynamics (USA) INC. | $40.07 | 2021-2023 | Optimizer |
| Alnylam Pharmaceuticals INC. | $39.42 | 2021 | |
| Philips North America LLC | $35.45 | 2019-2023 | |
| Kiniksa Pharmaceuticals International, Plc | $35.32 | 2024 | Arcalyst |
| Heartflow, INC. | $32.33 | 2024 | |
| Avinger INC. | $32.18 | 2020 | |
| Bard Peripheral Vascular, INC. | $31.84 | 2023-2024 | Venclose Maven Catheter |
| Lexicon Pharmaceuticals, INC. | $31.07 | 2023-2024 | Inpefa |
| Esperion Therapeutics, INC. | $28.73 | 2020-2021 | |
| Siemens Medical Solutions USA, INC. | $27.70 | 2023-2024 | Artis Icono Biplane, Artis Icono Floor |
| Atricure, INC. | $24.52 | 2022 | |
| Jazz Pharmaceuticals INC. | $17.06 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.15 | 2022 | |
| Janssen Biotech, INC. | $14.10 | 2023 | Tremfya |
| Cmp Pharma, INC. | $13.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.